Management of TSH 100 µIU/mL
A patient with TSH of 100 µIU/mL has severe overt primary hypothyroidism and requires immediate levothyroxine treatment to prevent life-threatening complications including myxedema coma.
Immediate Assessment
First, confirm this is primary hypothyroidism by checking free T4 (FT4), which will be low. If FT4 is also low with TSH this elevated, you have overt primary hypothyroidism requiring urgent treatment 1.
Critical warning signs requiring hospitalization:
- Bradycardia
- Hypothermia
- Altered mental status
- These indicate impending myxedema coma, a medical emergency 1
If any of these are present, admit immediately for IV levothyroxine, possible steroids, and intensive supportive care with endocrinology consultation 1.
Treatment Initiation
For patients WITHOUT cardiac disease or age <70 years:
Start full replacement dose immediately: approximately 1.6 mcg/kg/day based on ideal body weight 1. This aggressive approach is safe in younger patients without comorbidities and gets them to euthyroid status faster.
For patients WITH cardiac disease, age ≥70 years, or multiple comorbidities:
Start low and go slow: Begin with 25-50 mcg daily 1. The risk here is precipitating cardiac ischemia or arrhythmias with rapid thyroid hormone replacement. Titrate up gradually every 4-6 weeks based on TSH response.
Critical pitfall: In patients with long-standing severe hypothyroidism (which TSH 100 suggests), always consider concurrent adrenal insufficiency. If there's any uncertainty about adrenal function, give hydrocortisone BEFORE starting levothyroxine, as thyroid hormone can precipitate adrenal crisis 1.
Monitoring Strategy
- Recheck TSH and FT4 in 6-8 weeks after starting treatment 1
- Continue adjusting dose every 6-8 weeks until TSH normalizes
- Target TSH: 0.5-2.0 mIU/L for most patients 2
- FT4 can help interpret ongoing abnormal TSH, as TSH may lag behind clinical improvement 1
Once stable on appropriate dose, monitor TSH every 6-12 months 1.
Workup for Underlying Cause
While treating, investigate the etiology:
- Check anti-thyroid peroxidase (TPO) antibodies - most common cause in US is Hashimoto's thyroiditis 2, 3
- Review medication history (lithium, amiodarone, immune checkpoint inhibitors)
- Ask about prior radioiodine therapy or thyroid surgery
- Consider thyroid ultrasound if structural abnormality suspected
Common Pitfalls to Avoid
Don't wait to treat. TSH of 100 is not subclinical - this is severe overt hypothyroidism. There is no role for "watchful waiting" at this level 2, 3.
Don't under-replace. Many patients remain symptomatic because providers are too timid with dosing. Aim for TSH in lower half of normal range (0.5-2.0 mIU/L), not just "within range" 2.
Don't over-replace. Once stable, avoid suppressing TSH below 0.4 mIU/L, as this increases risks of atrial fibrillation and osteoporosis 2, 4.
Don't ignore persistent symptoms despite normalized TSH. If patient remains symptomatic with TSH 0.5-2.0 and normal FT4, consider checking FT3 levels and evaluating for other causes of fatigue. A small subset may benefit from T4/T3 combination therapy, though this remains controversial 4, 5.